Bilibili offers exposure to both small/mid-cap growth and international markets, counterbalancing U.S. tech concentration.

Canadian Natural Resources' strategy involves a 7.9% production boost in 2024, consistent reserves, share buybacks, and ...

LB Pharmaceuticals (LBRX) stock is on track for a Nasdaq listing as the company focused on neuropsychiatric diseases seeks a ...

ZIM's mixed H2'25 outlook offers insights on share prices, dividends, and potential privatization. Read more on why we have ...

Powell's Jackson Hole speech hinted at a September rate cut, but labor concerns and data show high uncertainty. Read why ...

Truist Financial continues to grow and is now a top-10 commercial bank in the U.S. Read what dividend investors need to know ...

Sinclair shares offer strong upside potential amid strategic reviews and M&A opportunities in a consolidating broadcast TV ...

We believe submarkets with projected occupancy rates above 96% in the next year are more likely to see accelerated rent ...

AMLP lags behind the market despite strong fundamentals and delivering a high single-digit dividend yield. Read more on why ...

Invest smartly during the FIFA World Cup! Learn how a balanced Nike and Adidas split outperforms the S&P 500, leveraging ...

Stock selection in the information technology and financials sectors contributed to the relative performance of the fund.

AbbVie has delivered strong returns and dividend growth, with solid prospects but notable risks creating near-term ...